vs
ALERUS FINANCIAL CORP（ALRS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
ALERUS FINANCIAL CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.3倍（$45.2M vs $35.5M），ALERUS FINANCIAL CORP净利率更高（-73.2% vs -304.2%，领先231.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 18.0%），ALERUS FINANCIAL CORP自由现金流更多（$58.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -2.5%）
阿勒鲁斯金融公司（品牌简称Alerus）是一家连锁金融机构，总部位于北达科他州大福克斯，网点分布在北达科他、明尼苏达、威斯康星与亚利桑那州，为客户提供银行、抵押贷款、财富管理以及退休规划等多种金融服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ALRS vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.2M | $35.5M |
| 净利润 | $-33.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -96.0% | -304.8% |
| 净利率 | -73.2% | -304.2% |
| 营收同比 | 18.0% | 681.7% |
| 净利润同比 | -49232.8% | 39.6% |
| 每股收益（稀释后） | $-1.27 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $45.2M | $35.5M | ||
| Q3 25 | $72.6M | $5.2M | ||
| Q2 25 | $74.8M | $19.2M | ||
| Q1 25 | $68.8M | $14.7M | ||
| Q4 24 | $72.2M | $4.5M | ||
| Q3 24 | $50.9M | $26.1M | ||
| Q2 24 | $51.4M | $14.4M | ||
| Q1 24 | $47.5M | $13.8M |
| Q4 25 | $-33.1M | $-108.1M | ||
| Q3 25 | $16.9M | $-162.3M | ||
| Q2 25 | $20.3M | $-171.9M | ||
| Q1 25 | $13.3M | $-202.5M | ||
| Q4 24 | $-67.0K | $-178.9M | ||
| Q3 24 | $5.2M | $-95.8M | ||
| Q2 24 | $6.2M | $-97.5M | ||
| Q1 24 | $6.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -96.0% | -304.8% | ||
| Q3 25 | 30.4% | -3327.6% | ||
| Q2 25 | 35.2% | -916.8% | ||
| Q1 25 | 25.5% | -1297.9% | ||
| Q4 24 | -0.8% | -4042.4% | ||
| Q3 24 | 13.4% | -377.1% | ||
| Q2 24 | 15.8% | -697.4% | ||
| Q1 24 | 17.9% | -698.4% |
| Q4 25 | -73.2% | -304.2% | ||
| Q3 25 | 23.3% | -3135.3% | ||
| Q2 25 | 27.1% | -894.2% | ||
| Q1 25 | 19.4% | -1373.3% | ||
| Q4 24 | -0.2% | -3935.5% | ||
| Q3 24 | 10.2% | -367.5% | ||
| Q2 24 | 12.1% | -676.6% | ||
| Q1 24 | 13.5% | -662.4% |
| Q4 25 | $-1.27 | $-0.17 | ||
| Q3 25 | $0.65 | $-0.36 | ||
| Q2 25 | $0.78 | $-0.41 | ||
| Q1 25 | $0.52 | $-0.50 | ||
| Q4 24 | $-0.06 | $-0.56 | ||
| Q3 24 | $0.26 | $-0.34 | ||
| Q2 24 | $0.31 | $-0.40 | ||
| Q1 24 | $0.32 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.2M | $743.3M |
| 总债务越低越好 | $59.2M | $9.6M |
| 股东权益账面价值 | $564.9M | $1.1B |
| 总资产 | $5.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.10× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $67.2M | $743.3M | ||
| Q3 25 | $92.0M | $659.8M | ||
| Q2 25 | $80.9M | $525.1M | ||
| Q1 25 | $83.0M | $500.5M | ||
| Q4 24 | $61.2M | $594.4M | ||
| Q3 24 | $66.0M | $427.6M | ||
| Q2 24 | $438.1M | $474.3M | ||
| Q1 24 | $545.8M | $296.3M |
| Q4 25 | $59.2M | $9.6M | ||
| Q3 25 | $59.2M | $11.9M | ||
| Q2 25 | $59.1M | $14.2M | ||
| Q1 25 | $59.1M | $16.4M | ||
| Q4 24 | $59.1M | $19.0M | ||
| Q3 24 | $59.0M | $20.5M | ||
| Q2 24 | $59.0M | $22.9M | ||
| Q1 24 | $59.0M | — |
| Q4 25 | $564.9M | $1.1B | ||
| Q3 25 | $550.7M | $1.0B | ||
| Q2 25 | $533.2M | $919.1M | ||
| Q1 25 | $514.2M | $933.9M | ||
| Q4 24 | $495.4M | $1.0B | ||
| Q3 24 | $386.5M | $524.6M | ||
| Q2 24 | $373.2M | $584.4M | ||
| Q1 24 | $371.6M | $401.2M |
| Q4 25 | $5.2B | $1.5B | ||
| Q3 25 | $5.3B | $1.4B | ||
| Q2 25 | $5.3B | $1.3B | ||
| Q1 25 | $5.3B | $1.3B | ||
| Q4 24 | $5.3B | $1.4B | ||
| Q3 24 | $4.4B | $726.5M | ||
| Q2 24 | $4.4B | $775.9M | ||
| Q1 24 | $4.3B | $557.8M |
| Q4 25 | 0.10× | 0.01× | ||
| Q3 25 | 0.11× | 0.01× | ||
| Q2 25 | 0.11× | 0.02× | ||
| Q1 25 | 0.11× | 0.02× | ||
| Q4 24 | 0.12× | 0.02× | ||
| Q3 24 | 0.15× | 0.04× | ||
| Q2 24 | 0.16× | 0.04× | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $58.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 130.2% | -133.1% |
| 资本支出强度资本支出/营收 | 19.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $102.4M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $67.5M | $-46.1M | ||
| Q3 25 | $32.8M | $-117.4M | ||
| Q2 25 | $10.7M | $-76.4M | ||
| Q1 25 | $7.7M | $-132.0M | ||
| Q4 24 | $21.7M | $-115.4M | ||
| Q3 24 | $20.2M | $-59.2M | ||
| Q2 24 | $-12.5M | $-82.2M | ||
| Q1 24 | $11.7M | $-102.3M |
| Q4 25 | $58.8M | $-47.3M | ||
| Q3 25 | $30.3M | $-117.6M | ||
| Q2 25 | $7.6M | $-79.6M | ||
| Q1 25 | $5.7M | $-133.8M | ||
| Q4 24 | $9.4M | $-116.7M | ||
| Q3 24 | $17.4M | $-63.8M | ||
| Q2 24 | $-16.1M | $-83.4M | ||
| Q1 24 | $10.8M | $-109.0M |
| Q4 25 | 130.2% | -133.1% | ||
| Q3 25 | 41.8% | -2272.5% | ||
| Q2 25 | 10.1% | -413.9% | ||
| Q1 25 | 8.2% | -907.4% | ||
| Q4 24 | 13.0% | -2567.7% | ||
| Q3 24 | 34.2% | -244.6% | ||
| Q2 24 | -31.4% | -578.5% | ||
| Q1 24 | 22.8% | -789.9% |
| Q4 25 | 19.3% | 3.5% | ||
| Q3 25 | 3.4% | 4.7% | ||
| Q2 25 | 4.2% | 16.4% | ||
| Q1 25 | 3.0% | 12.4% | ||
| Q4 24 | 17.1% | 28.6% | ||
| Q3 24 | 5.4% | 17.5% | ||
| Q2 24 | 7.2% | 8.2% | ||
| Q1 24 | 1.9% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.94× | — | ||
| Q2 25 | 0.53× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.88× | — | ||
| Q2 24 | -2.01× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALRS
| Other | $17.3M | 38% |
| Retirement And Benefit Services | $17.3M | 38% |
| Wealth Management | $7.4M | 16% |
| Mortgage Banking | $3.2M | 7% |
RXRX
暂无分部数据
